Le Lézard
Classified in: Health
Subjects: AVO, CPG

Presumed consent to human tissue donation: Héma-Québec submits its thoughts and recommendations


QUÉBEC, Jan. 30, 2024 /CNW/ - Héma?Québec participates in the public hearings of the Committee on Health and Social Services of the Assemblée nationale du Québec, which has the order of initiative to look into ways to facilitate organ and tissue donation, notably the adoption of presumed consent.

"As the organization responsible for the collection, processing, and distribution of human tissues for grafting within the province, Héma-Québec commends the initiative of the members who are seeking to improve the organ and tissue donation system in Québec. Currently, in Québec, such donations are based on the consent given either by the donor during their lifetime or by their loved ones after death. Therefore, moving to presumed consent would be a major paradigm shift," stated Dr. Marc Germain, Vice-President of Medical Affairs and Innovation at Héma-Québec.

Here is a summary of Héma-Québec's main thoughts and recommendations about presumed consent:

About Héma-Québec's Human Tissue Bank

Héma-Québec's Human Tissue Bank is the largest human tissue bank in Canada, with the highest volume and variety of transplants available; the main transplanted tissues are bones, heart valves, tendons, and corneas. As of fall 2024, under the new mandate given to it by the Ministère de la Santé et des Services sociaux, Héma-Québec will provide the full supply of human tissues to Québec's hospitals.

About Héma-Québec

Héma-Québec's mission is to efficiently meet the Québec population's needs for blood and other high-quality biological products of human origin. Héma-Québec has over 1,600 employees, more than 200,000 donors of blood, stem cells, mother's milk and human tissues, as well as thousands of blood drive volunteers. Every year, Héma-Québec delivers nearly 800,000 biological products of human origin to Québec's hospitals in order to meet patients' needs.

Give blood. Give life.

www.hema-quebec.qc.ca

SOURCE Héma-Québec


These press releases may also interest you

26 avr 2024
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

26 avr 2024
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

26 avr 2024
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

26 avr 2024
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

26 avr 2024
David J. Dykeman, co-chair of the Life Sciences & Medical...

26 avr 2024
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: